Watchlist Price Alert

Actinium Pharmaceuticals ... (ATNM)

AMEX: ATNM · Real-Time Price · USD

1.53

-0.02 (-1.29%)

At close: May 13, 2025, 3:59 PM

1.47

-3.92%

After-hours: May 13, 2025, 07:55 PM EDT

Actinium Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	81K	1.03M	1.14M	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	699K	524K	447K	420.09K	50.72K	55.94K	77.52K
Gross Profit	n/a	81K	331K	620K	-447K	-420.09K	-50.72K	-55.94K	-77.52K
Operating Income	-42.12M	-51.92M	-34.1M	-24.96M	-22.39M	-22.07M	-23.83M	-26.91M	-26.85M
Interest Income	n/a	3.1M	1.09M	190K	178K	172.39K	173.36K	5.43K	n/a
Pretax Income	-38.24M	-48.82M	-33.02M	-24.77M	-22.21M	-21.9M	-23.65M	-26.6M	-24.32M
Net Income	-38.24M	-48.82M	-31.93M	-24.58M	-22.04M	-21.73M	-23.65M	-26.6M	-24.32M
Selling & General & Admin	12.08M	13.33M	12M	8.08M	6.31M	5.52M	6.73M	9.16M	9.27M
Research & Development	30.05M	38.67M	23.14M	18.03M	16.09M	16.55M	17.09M	17.7M	17.5M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	55.94K	77.52K
Operating Expenses	42.12M	52M	35.13M	26.11M	22.39M	22.07M	23.83M	26.91M	26.85M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	173.36K	5.43K	5.01K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	52M	35.13M	26.11M	22.39M	22.07M	23.83M	26.91M	26.85M
Income Tax Expense	n/a	n/a	-1.09M	-190K	-178K	-172.39K	173.36K	-309.55K	5.01K
Shares Outstanding (Basic)	30.07M	26.6M	24.14M	20.57M	12.13M	4.98M	3.53M	2.22M	1.62M
Shares Outstanding (Diluted)	30.07M	26.6M	24.14M	20.57M	12.13M	4.98M	3.53M	2.22M	1.62M
EPS (Basic)	-1.27	-1.83	-1.32	-1.2	-1.82	-4.37	-6.69	-11.96	-15.06
EPS (Diluted)	-1.27	-1.83	-1.32	-1.2	-1.82	-4.37	-6.69	-11.96	-15.06
EBITDA	-37.43M	-51.13M	-33.41M	-24.44M	-21.77M	-21.48M	-23.78M	-26.85M	-26.77M
EBIT	n/a	-51.92M	-34.1M	-24.96M	-22.21M	-21.9M	-23.83M	-26.91M	-26.85M
Depreciation & Amortization	n/a	790K	699K	524K	447K	420.09K	50.72K	55.94K	77.52K